Use of the Comet Assay to Detect Hypoxic Cells in Murine Tumours and Normal Tissues Exposed to Bioreductive Drugs

References

• Östling O, Johanson K J. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 1984; 123: 291–8
   PubMed Web of Science ®Google Scholar
• Olive P L, Durand R E. Detecting hypoxic cells in a murine tumour using the comet assay. J Natl Cancer Inst 1992; 85: 707–11
   Google Scholar
• Olive P L, Durand R E, LeRiche J, Olivotto I, Jackson S M. Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers. Cancer Res 1993; 53: 733–6
   PubMed Web of Science ®Google Scholar
• Olive P L. Radiation-induced reoxygenation in the SCCVII murine tumour: evidence for a decrease in oxygen consumption and an increase in tumour perfusion. Radiother Oncol 1994; 32: 37–46
   PubMedGoogle Scholar
• Olive P L, Vikse C M, Durand R E. Hypoxic fractions measured in murine tumours and normal tissues using the comet assay. Int J Radiat Oncol Biol Phys 1994; 20: 487–91
   Google Scholar
• Zeman E M, Brown J M, Lemon M J, Hirst V K, Lee W W. SR 4233: a new bioreductive agent with high selective toxicity for mammalian cells. Int J Radiat Oncol Biol Phys 1986; 12: 1239–41
   PubMed Web of Science ®Google Scholar
• Stratford I J, O'Neill P, Sheldon P W, Silver A RJ, Walling J M, Adams G E. RSU 1069, a nitroimidazole containing an aziridine group: Bioreduction greatly increases cytotoxicity under hypoxic conditions. Biochem Pharmacol 1986; 35: 105–10
   PubMed Web of Science ®Google Scholar
• Whitmore G F, Gulyas S. Studies on the toxicity of RSU 1069. Int J Radiat Oncol Biol Phys 1986; 12: 1219–22
   PubMedGoogle Scholar
• Wang J, Biedermann K A, Wolf C R, Brown J M. Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies. Br J Cancer 1993; 67: 321–5
   PubMedGoogle Scholar
• Workman P, Walton M I. Pharmacology of the mixed function radio- and chemosensitizers CB 1954 and RSU 1069. Int J Radiat Oncol Biol Phys 1984; 10: 1307–10
   PubMed Web of Science ®Google Scholar
• Brown J M. SR4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br J Cancer 1993; 67: 1163–7
   PubMed Web of Science ®Google Scholar
• Wang J, Biedermann K A, Brown J M. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation. Cancer Res 1992; 52: 4473–7
   PubMedGoogle Scholar
• Laderoute K, Wardman P, Rauth A M. Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2-4-benzotriazine 1,4-dioxide (SR 4233). Biochem Pharmacol 1988; 37: 1487–95
   PubMed Web of Science ®Google Scholar
• O'Neill P, McNeil S S, Jenkins T C. Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole-aziridines RSU 1069 and RSU-1131. Biochem Pharmacol 1987; 36: 1787–92
   PubMed Web of Science ®Google Scholar
• Silver A RJ, O'Neill P, Jenkins T C. Induction of DNA strand breaks by RSU 1069, a nitroimiazole-aziridine radiosensitizer. Biochem Pharmacol 1985; 34: 3537–42
   PubMed Web of Science ®Google Scholar
• Olive P L. Detection of hypoxia in individual cells of spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine. Br J Cancer 1995; 71: 529–36
   PubMed Web of Science ®Google Scholar
• Olive P L. Detection of hypoxia in individual cells of spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069. Br J Cancer 1995; 71: 537–42
   PubMedGoogle Scholar
• Spiegel J F, Spear M A, Brown J M. Toxicology of daily administration to mice of the radiation potentiator tirapaz-amine (WIN 59075). Radiother Oncol 1993; 26: 79–81
   PubMedGoogle Scholar
• Sebolt-Leopold S, Vincent P W, Beningo K A, et al. Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agents. Int J Radiat Oncol Biol Phys 1992; 22: 549–51
   PubMedGoogle Scholar
• Olive P L. Distribution, oxygenation and clonogenicity of macrophages in a murine tumour. Cancer Commun 1989; 2: 93–100
   Google Scholar
• Allalunis-Turner M J, Chapman J D, Turner A R. Identification of a hypoxic population of bone marrow cells. Int J Radiat Oncol Biol Phys 1983; 9: 227–32
   PubMedGoogle Scholar
• Joshi D S, Yick J, Murray D, Meistrich M L. Stage-dependent variation in the radiosensitivity of DNA in developing male germ cells. Radiat Res 1990; 121: 274–8
   PubMedGoogle Scholar
• Koch C J. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. Cancer Res 1993; 53: 3992–7
   PubMed Web of Science ®Google Scholar